Traws Pharma, Inc. (TRAW) income statement
TRAWNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.17−0.06 (-23.91%)
Close on Nov 20, 2026Market cap $2.69MP/E –Yield –
Traws Pharma, Inc. financial ratios
See a number that looks wrong?
Close on Nov 20, 2026Market cap $2.69MP/E –Yield –
See a number that looks wrong?
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Margins | ||||||||||||||||
| Operating margin | -640.7% | -62,997.3% | -8,981.4% | -8,684.5% | -7,299.1% | -10,819.5% | -994.0% | -1,895.9% | -3,270.3% | -427.4% | -209.3% | -7,968.0% | -1,309.1% | -48.2% | -1,854.3% | – |
| EBITDA margin | -638.5% | -62,992.0% | -8,974.3% | -8,678.3% | -7,292.9% | -10,813.9% | -993.4% | -1,891.4% | -3,259.1% | -425.7% | -207.9% | -7,913.8% | -1,299.7% | -47.5% | -1,833.0% | – |
| Pre-tax margin | 328.7% | -73,684.1% | -8,384.1% | -8,391.2% | -7,151.8% | -10,888.7% | -984.6% | -1,672.1% | -3,059.6% | -354.4% | -209.6% | -7,972.0% | -1,307.0% | -64.8% | -1,768.3% | – |
| Net profit margin | 328.7% | -73,682.7% | -8,384.1% | -8,391.2% | -7,151.8% | -10,890.5% | -985.0% | -1,675.3% | -3,061.2% | -354.6% | -209.3% | -7,960.3% | -1,315.9% | -64.8% | -1,768.3% | – |
| Free cash flow margin | -744.4% | -14,796.5% | -7,940.7% | – | – | -9,995.7% | -956.8% | – | – | – | – | -7,234.5% | -1,304.3% | 2.9% | -970.2% | – |
| Returns on capital | ||||||||||||||||
| Return on equity | -42.6% | 521.7% | -97.2% | -51.0% | -61.8% | -283.5% | -253.6% | 652.7% | 651.7% | -274.9% | -146.4% | -123.5% | 166.5% | 22.8% | 24.5% | – |
| Return on assets | 51.5% | -699.0% | -61.1% | -40.0% | -42.8% | -115.2% | -103.4% | -179.7% | -170.8% | -84.3% | -67.8% | -83.5% | -66.2% | -35.7% | – | – |
| Return on tangible assets | 60.1% | -699.0% | -61.1% | -40.0% | -42.8% | -115.2% | -103.4% | -179.7% | -170.8% | -84.3% | -67.8% | -83.5% | -66.2% | -35.7% | – | – |
| Return on capital employed | -277.1% | -1,058.9% | -90.6% | -48.6% | -55.6% | -197.2% | -174.5% | -1,037.5% | -637.4% | -164.0% | -90.6% | -96.7% | -81.2% | -38.1% | – | – |
| NOPAT | -$14.12M | -$112.48M | -$16.04M | -$15.51M | -$13.03M | -$19.74M | -$17.14M | -$18.39M | -$20.33M | -$18.73M | -$18.94M | -$50.36M | -$49.16M | -$17.60M | -$21.78M | – |
| Cash flow quality | ||||||||||||||||
| OCF / Sales | -651.8% | -13,182.3% | -7,934.5% | -7,209.7% | -8,622.6% | -9,989.2% | -954.2% | -1,848.2% | -3,026.7% | -285.1% | -272.7% | -7,206.0% | -1,291.5% | 3.5% | -953.0% | – |
| OCF / Net income | -1.98 | 0.18 | 0.95 | 0.86 | 1.21 | 0.92 | 0.97 | 1.10 | 0.99 | 0.80 | 1.30 | 0.91 | 0.98 | -0.05 | 0.54 | – |
| FCF / OCF | 114.2% | 112.2% | 100.1% | – | – | 100.1% | 100.3% | – | – | – | – | 100.4% | 101.0% | 82.9% | 101.8% | – |
| FCF / Net income | -2.26 | 0.20 | 0.95 | – | – | 0.92 | 0.97 | – | – | – | – | 0.91 | 0.99 | -0.05 | 0.55 | – |
| FCF / EBITDA | 116.6% | 23.5% | 88.5% | – | – | 92.4% | 96.3% | – | – | – | – | 91.4% | 100.4% | -6.2% | 52.9% | – |
| Unlevered free cash flow | -$20.77M | -$33.44M | -$17.95M | – | – | -$23.09M | -$20.89M | – | – | – | – | -$57.87M | -$61.99M | $8.15M | -$14.41M | – |
| Levered free cash flow | -$20.77M | -$33.44M | -$17.95M | – | – | -$23.09M | -$20.89M | – | – | – | – | -$57.88M | -$61.99M | $1.35M | -$14.43M | – |
| Efficiency | ||||||||||||||||
| Asset turnover | 0.16 | 0.01 | 0.01 | 0.00 | 0.01 | 0.01 | 0.10 | 0.11 | 0.06 | 0.24 | 0.32 | 0.01 | 0.05 | 0.55 | – | – |
| Fixed asset turnover | 328.24 | 14.13 | 9.83 | 7.29 | 5.02 | 4.53 | 74.00 | 33.64 | 7.29 | 27.73 | 34.30 | 1.53 | 8.73 | 99.76 | – | – |
| Receivables turnover | 1.00 | 0.25 | 9.62 | 7.93 | 6.95 | 3.42 | 32.83 | 26.13 | 17.49 | 7.23 | 14.00 | 6.06 | – | – | – | – |
| Days sales outstanding | 363.6 | 1,439.8 | 38.0 | 46.0 | 52.5 | 106.7 | 11.1 | 14.0 | 20.9 | 50.5 | 26.1 | 60.2 | – | – | – | – |
| CapEx to revenue | 92.7% | 1,614.2% | 6.2% | – | – | 6.5% | 2.5% | – | – | – | – | 28.5% | 12.8% | 0.60% | 17.2% | – |
| CapEx to OCF | -14.2% | -12.2% | -0.08% | – | – | -0.07% | -0.26% | – | – | – | – | -0.40% | -0.99% | 17.1% | -1.8% | – |
| CapEx to depreciation | 42.38 | 304.00 | 0.88 | – | – | 1.15 | 3.93 | – | – | – | – | 0.53 | 1.37 | 0.87 | 0.81 | – |
| Liquidity | ||||||||||||||||
| Current ratio | 0.72 | 2.16 | 2.46 | 4.89 | 9.06 | 1.97 | 2.83 | 2.11 | 0.49 | 2.27 | 3.05 | 4.57 | 10.10 | 3.28 | – | – |
| Quick ratio | 0.72 | 2.16 | 2.46 | 4.89 | 9.06 | 1.97 | 2.83 | 2.11 | 0.49 | 2.27 | 3.05 | 4.57 | 10.10 | 3.28 | – | – |
| Cash ratio | 0.34 | 1.85 | 2.26 | 4.82 | 9.01 | 1.90 | 2.74 | 2.01 | 0.40 | 2.11 | 2.61 | 4.25 | 5.80 | 3.21 | – | – |
| Working capital | -$3.17M | $13.42M | $13.44M | $31.30M | $49.32M | $9.76M | $15.18M | $9.33M | -$5.07M | $12.91M | $15.58M | $36.65M | $94.05M | $57.87M | – | – |
| Net current asset value | -$3.27M | -$31.64M | $10.65M | $28.28M | $46.07M | $5.97M | $11.37M | $5.23M | -$10.94M | $4.96M | $10.58M | $23.19M | $80.14M | $42.41M | – | – |
| Leverage | ||||||||||||||||
| Assets to equity | -16.88 | -0.79 | 2.13 | 1.39 | 1.20 | 3.24 | 2.05 | 3.33 | -0.43 | 5.41 | 2.34 | 2.08 | 1.31 | -0.53 | – | – |
| Intangibles to total assets | 23.8% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Interest coverage | ||||||||||||||||
| EBIT / Interest expense | – | – | – | – | – | – | – | – | – | – | – | -31,872.00 | -15,555.50 | -2.59 | -1,451.21 | – |
| EBITDA / Interest expense | – | – | – | – | – | – | – | – | – | – | – | -31,655.00 | -15,444.00 | -2.55 | -1,434.58 | – |
| (EBITDA − CapEx) / Interest expense | – | – | – | – | – | – | – | – | – | – | – | -31,769.00 | -15,596.25 | -2.58 | -1,448.05 | – |
| Per share | ||||||||||||||||
| Revenue per share | 0.31 | 0.06 | 0.27 | 0.27 | 0.27 | 0.47 | 7.36 | 81.16 | 410.97 | 4,613.98 | 25,289.18 | 2,072.54 | 12,442.41 | 1,004,130.43 | 39,131.58 | – |
| EPS (basic) | 0.83 | -35.21 | -22.57 | -22.75 | -24.00 | -54.25 | -558.75 | -1,871.25 | -15,056.25 | -24,975.00 | -59,287.50 | -165,375.00 | -344,250.00 | -863,437.50 | -797,625.00 | – |
| EPS (diluted) | 0.82 | -35.21 | -22.57 | -22.75 | -24.00 | -54.25 | -558.75 | -1,871.25 | -15,056.25 | -24,975.00 | -59,287.50 | -165,375.00 | -344,250.00 | -863,437.50 | -797,625.00 | – |
| Book value per share | -0.07 | -8.66 | 12.70 | 33.82 | 55.18 | 12.45 | 39.04 | 356.02 | -6,104.96 | 3,574.88 | 22,097.13 | 58,932.64 | 210,505.24 | -3,441,434.78 | -3,642,605.26 | – |
| Tangible book value per share | -0.35 | -8.66 | 12.70 | 33.82 | 55.18 | 12.45 | 39.04 | 356.02 | -6,104.96 | 3,574.88 | 22,097.13 | 58,932.64 | 210,505.24 | -3,441,434.78 | -3,642,605.26 | – |
| Cash per share | 0.42 | 5.84 | 24.78 | 46.30 | 65.89 | 38.37 | 76.66 | 1,121.54 | 2,101.31 | 17,845.26 | 43,816.78 | 112,906.74 | 157,091.62 | 1,772,326.09 | 71,394.74 | – |
| Operating cash flow per share | -2.01 | -8.16 | -21.34 | -19.47 | -23.31 | -46.54 | -70.27 | -1,499.97 | -12,438.64 | -13,155.57 | -68,958.06 | -149,347.15 | -160,691.10 | 35,500.00 | -372,921.05 | – |
| Free cash flow per share | -2.29 | -9.16 | -21.36 | – | – | -46.57 | -70.45 | – | – | – | – | -149,937.82 | -162,285.34 | 29,434.78 | -379,657.89 | – |
| CapEx per share | 0.29 | 1.00 | 0.02 | – | – | 0.03 | 0.19 | – | – | – | – | 590.67 | 1,594.24 | 6,065.22 | 6,736.84 | – |
| Valuation at period end | ||||||||||||||||
| Market cap | $8.06M | $26.87M | $15.66M | $13.60M | $53.27M | $86.74M | $3.14M | $11.97M | $14.77M | $15.35M | $22.73M | $71.43M | $246.03M | – | – | – |
| Enterprise value | $1.64M | $21.46M | -$9.58M | -$29.01M | -$6.11M | $62.54M | -$1.68M | -$10.41M | $8.00M | -$9.60M | $1.37M | $29.48M | $169.42M | – | – | – |
| P/E | 0.9x | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| P/S | 2.9x | 119x | 69.3x | 60.2x | 236x | 375x | 1.4x | 9.7x | 18.8x | 2.8x | 2.0x | 89.3x | 51.8x | – | – | – |
| P/B | -12.8x | -0.8x | 1.5x | 0.5x | 1.2x | 14.0x | 0.3x | 2.2x | -1.3x | 3.6x | 2.3x | 3.1x | 3.1x | – | – | – |
| P/TBV | -2.6x | -0.8x | 1.5x | 0.5x | 1.2x | 14.0x | 0.3x | 2.2x | -1.3x | 3.6x | 2.3x | 3.1x | 3.1x | – | – | – |
| P/OCF | -0.4x | -0.9x | -0.9x | -0.8x | -2.7x | -3.8x | -0.2x | -0.5x | -0.6x | -1.0x | -0.7x | -1.2x | -4.0x | – | – | – |
| EV/Sales | 0.6x | 94.9x | -42.4x | -128x | -27.0x | 271x | -0.8x | -8.5x | 10.2x | -1.7x | 0.1x | 36.9x | 35.6x | – | – | – |
| EV/EBITDA | – | – | 0.5x | 1.5x | 0.4x | – | 0.1x | 0.4x | – | 0.4x | – | – | – | – | – | – |
| EV/EBIT | – | – | 0.5x | 1.5x | 0.4x | – | 0.1x | 0.4x | – | 0.4x | – | – | – | – | – | – |
| EV/OCF | -0.1x | -0.7x | 0.5x | 1.8x | 0.3x | -2.7x | 0.1x | 0.5x | -0.3x | 0.6x | -0.0x | -0.5x | -2.8x | – | – | – |
| EV/FCF | – | – | 0.5x | – | – | – | 0.1x | – | – | – | – | – | – | – | – | – |
| Earnings yield | 113.8% | -619.8% | -121.0% | – | – | -29.0% | -684.9% | -171.8% | -163.1% | -128.2% | -105.5% | -89.1% | -25.4% | – | – | – |
| FCF yield | -257.7% | -124.5% | -114.6% | – | – | -26.6% | -665.3% | – | – | – | – | -81.0% | -25.2% | – | – | – |
| Cost structure | ||||||||||||||||
| R&D to revenue | 435.2% | 5,684.5% | 5,057.5% | 5,046.9% | 3,228.8% | 7,315.2% | 711.7% | 1,378.2% | 2,429.4% | 361.9% | 226.0% | 6,178.1% | 1,055.8% | 114.2% | 1,521.5% | – |
| Stock-based comp to revenue | 26.1% | 615.0% | 575.7% | 518.6% | 254.9% | 159.7% | 48.0% | 93.4% | 217.3% | 70.8% | 33.0% | 633.5% | 168.6% | 30.0% | 0.40% | – |
| Per employee | ||||||||||||||||
| Total employees | 7 | 17 | 17 | 17 | 15 | 12 | 19 | 25 | 25 | 23 | 36 | 50 | 64 | 64 | 64 | 64 |
| Revenue per employee | $398.57K | $13.29K | $13.29K | $13.29K | $15.07K | $19.25K | $114.89K | $49.12K | $31.48K | $241.13K | $318.22K | $16.00K | $74.27K | $721.72K | $23.23K | – |
| Operating profit per employee | -$2.55M | -$8.37M | -$1.19M | -$1.15M | -$1.10M | -$2.08M | -$1.14M | -$931.28K | -$1.03M | -$1.03M | -$665.89K | -$1.27M | -$972.22K | -$348.11K | -$430.83K | – |
| Net income per employee | $1.31M | -$9.80M | -$1.11M | – | – | -$2.10M | -$1.13M | -$822.92K | -$963.68K | -$855.09K | -$666.08K | -$1.27M | -$977.23K | -$467.38K | -$410.84K | – |
| Free cash flow per employee | -$2.97M | -$1.97M | -$1.06M | – | – | -$1.92M | -$1.10M | – | – | – | – | -$1.16M | -$968.64K | $21.16K | -$225.42K | – |
| Growth | ||||||||||||||||
| Revenue 1Y growth | 1,134.5% | 0.00% | 0.00% | 0.00% | -2.2% | -89.4% | 77.8% | 56.0% | -85.8% | -51.6% | 1,332.0% | -83.2% | -89.7% | 3,006.3% | – | – |
| Revenue 3Y CAGR | 131.1% | 0.00% | -0.73% | -53.0% | -43.1% | -33.5% | -26.7% | -52.5% | -0.54% | 5.3% | -37.2% | -18.7% | – | – | – | – |
| Revenue 5Y CAGR | 64.6% | -36.5% | -28.7% | -22.1% | -47.3% | -54.2% | 22.2% | -23.7% | -55.7% | 30.1% | – | – | – | – | – | – |
| Revenue 10Y CAGR | -13.2% | -11.9% | -26.3% | -41.3% | -17.2% | – | – | – | – | – | – | – | – | – | – | – |
| EBIT 1Y growth | 87.4% | -601.4% | -3.4% | -19.0% | 34.0% | -15.2% | 6.8% | 9.5% | -8.6% | 1.1% | 62.4% | -2.4% | -179.3% | 19.2% | – | – |
| EBITDA 1Y growth | 87.5% | -601.9% | -3.4% | -19.0% | 34.0% | -15.2% | 6.6% | 9.4% | -8.6% | 0.90% | 62.4% | -2.5% | -181.3% | 19.4% | – | – |
| Net income 1Y growth | 105.5% | -778.8% | 0.08% | -17.3% | 35.8% | -17.0% | -4.5% | 14.6% | -22.5% | 18.0% | 62.3% | -1.8% | -109.1% | -13.8% | – | – |
| Diluted EPS 1Y growth | 102.3% | -56.0% | 0.79% | 5.2% | 55.8% | 90.3% | 70.1% | 87.6% | 39.7% | 57.9% | 64.1% | 52.0% | 60.1% | -8.3% | – | – |
| Operating cash flow 1Y growth | 39.0% | -66.1% | -10.1% | 16.4% | 15.5% | -10.8% | 8.2% | 4.7% | -50.6% | 49.4% | 45.8% | 6.1% | -3,859.0% | 111.5% | – | – |
| Free cash flow 1Y growth | 37.9% | -86.3% | – | – | – | -10.6% | – | – | – | – | – | 6.6% | -4,678.5% | 109.4% | – | – |
| CapEx 1Y growth | -29.1% | 25,957.1% | – | – | – | -72.7% | – | – | – | – | – | -62.6% | 118.3% | 9.0% | – | – |
| CapEx 3Y CAGR | – | – | -2.3% | – | – | – | – | – | – | – | – | -3.8% | – | – | – | – |
| CapEx 5Y CAGR | 180.1% | 131.4% | – | – | – | – | -24.8% | – | – | – | – | – | – | – | – | – |
| CapEx 10Y CAGR | – | 32.0% | -31.4% | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Total assets 1Y growth | -57.5% | 10.0% | -42.4% | -29.0% | 177.6% | -15.6% | 32.1% | 260.0% | -78.6% | -0.90% | -50.5% | -55.0% | 25.4% | – | – | – |
| Total assets 3Y CAGR | -35.4% | -23.4% | 4.3% | 18.5% | 45.7% | 58.9% | 0.63% | -8.6% | -52.8% | -39.5% | -34.6% | – | – | – | – | – |
| Total assets 5Y CAGR | -11.9% | 1.1% | 4.8% | 51.2% | 19.0% | -3.1% | -12.9% | -29.8% | -43.2% | – | – | – | – | – | – | – |
| Total assets 10Y CAGR | -7.6% | -6.2% | -14.2% | -7.3% | – | – | – | – | – | – | – | – | – | – | – | – |
| Total equity 1Y growth | – | – | – | – | – | – | 114.9% | 146.1% | -372.1% | -57.1% | -56.0% | -71.7% | 150.8% | -14.4% | – | – |
| Total equity 3Y CAGR | – | – | – | – | – | – | 39.1% | -18.7% | – | -62.3% | – | – | – | – | – | – |
| Total equity 5Y CAGR | – | – | – | – | – | – | -12.6% | -41.8% | – | – | – | – | – | – | – | – |
Every figure here is calculated from standardized financial statements — hover a row name for the formula — not reported by the company. Valuation multiples use the closing price at the end of that period, not today's price.